Steady, Sustained Weight Loss: Many patients can expect to lose as much as ten pounds within four to six weeks of starting their weight loss program
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
doi: 10.1016/j.bbrc.2010.12.131 121 HanYLiuWChenLXinXWangQZhangXet al
Valenzuela-Vallejo L, Guatibonza-Garcia V, Mantzoros CS
Programs like Nooms Microdose GLP-1Rx Program target metabolic reset over rapid weight loss, using doses at 25% or less of standard maintenance dosing
Half of the patients (50%) treated with colesevelam (N = 26) experienced 25% reduction in the number of bowel movements per day, whereas a significantly greater proportion (77%) of patients treated with liraglutide (N = 26) met the primary endpoint (20)